The treatment landscape of generalised myasthenia gravis, a prototypic antibody-mediated disorder of the neuromuscular junction, has considerably evolved in the past 8 years.1 The approval of targeted ...

A multidisciplinary panel convened by the American College of Critical Care Medicine has developed new guideline ...

Despite data gaps in many countries, the burden of sickle cell disease, especially in west and central Africa, underscores the urgent need to scale up newborn and early childhood screening, ...

Bangladesh is experiencing a measles resurgence with unprecedented numbers of severe paediatric cases. As of March 30, 2026, nationwide deaths increased to at least 38 children, including 32 deaths in ...

Scientists, clinicians, policymakers, and patients from 20 countries and 43 institutions gathered for the inaugural World Brain Health Forum 2026 in Paris (France) to discuss an increasingly urgent ...

The CURE-ND initiative was created in 2020 as a strategic partnership across leading European research institutes. CURE-ND brings together four leading national institutes (the Deutsches Zentrum für ...

Camillo Golgi (1843–1926) delivered his 1906 Nobel lecture The Neuron Doctrine – Theory and Facts1 before the Royal Swedish Academy of Sciences and in the presence of his Nobel co-laureate Santiago ...

For decades, the treatment of developmental and epileptic encephalopathies has focused on suppressing seizures rather than modifying the underlying biology of disease. In the New England Journal of ...

High blood pressure is the main modifiable risk factor for preventing cardiovascular events in people who have had a stroke or transient ischaemic attack; however, only approximately one in three ...

The importance of strengthening brain health and brain skills to transform patient outcomes and the economics of health ...

As part of a continuing series, Talha Burki looks at the issues at the core of medicine in nuclear power plants.

Efficacy and safety of co-administered cagrilintide and semaglutide versus semaglutide alone in adults with overweight or obesity with or without type 2 diabetes in Japan and Taiwan (REDEFINE 5): a ...